Skip to main content

Viloxazine: A review of the literature

Publication ,  Journal Article
Ban, TA; McEvoy, JP; Wilson, WH
Published in: International Pharmacopsychiatry
1980

In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

Duke Scholars

Published In

International Pharmacopsychiatry

Publication Date

1980

Volume

15

Issue

2

Start / End Page

118 / 123

Related Subject Headings

  • Psychiatry
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ban, T. A., McEvoy, J. P., & Wilson, W. H. (1980). Viloxazine: A review of the literature. International Pharmacopsychiatry, 15(2), 118–123.
Ban, T. A., J. P. McEvoy, and W. H. Wilson. “Viloxazine: A review of the literature.” International Pharmacopsychiatry 15, no. 2 (1980): 118–23.
Ban TA, McEvoy JP, Wilson WH. Viloxazine: A review of the literature. International Pharmacopsychiatry. 1980;15(2):118–23.
Ban, T. A., et al. “Viloxazine: A review of the literature.” International Pharmacopsychiatry, vol. 15, no. 2, 1980, pp. 118–23.
Ban TA, McEvoy JP, Wilson WH. Viloxazine: A review of the literature. International Pharmacopsychiatry. 1980;15(2):118–123.

Published In

International Pharmacopsychiatry

Publication Date

1980

Volume

15

Issue

2

Start / End Page

118 / 123

Related Subject Headings

  • Psychiatry
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences